Literature DB >> 2168958

Linker insertion mutagenesis of herpesviruses: inactivation of single genes within the Us region of pseudorabies virus.

N de Wind1, A Zijderveld, K Glazenburg, A Gielkens, A Berns.   

Abstract

We describe a technique for the systematic inactivation of nonessential genes within the genome of a herpesvirus without the requirement for phenotypic selection. This technique is based on the insertion of an oligonucleotide containing translational stop codons at a random site within a large cloned viral DNA fragment. Mutant virus is then reconstituted by cotransfection with overlapping viral clones, together comprising the entire viral genome, as described previously (M. van Zijl, W. Quint, J. Briaire, T. de Rover, A. Gielkens, and A. Berns, J. Virol. 62:2191-2195, 1988). This technique was used to construct, in a single experiment, a set of 13 viable pseudorabies virus strains with oligonucleotide insertions within all known genes of the Us region except for the gp50 gene, which proved essential for virus growth in cell culture. The growth rate in porcine kidney cells of mutants of all nonessential Us genes was similar to that of the parental virus, with the exception of a mutant of the recently identified protein kinase gene.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168958      PMCID: PMC247954          DOI: 10.1128/JVI.64.10.4691-4696.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Analysis of the structure of the genome of pseudorabies virus.

Authors:  T Ben-Porat; F J Rixon; M L Blankenship
Journal:  Virology       Date:  1979-06       Impact factor: 3.616

2.  Electron microscopic studies of the DNA of defective and standard pseudorabies virions.

Authors:  A S Rubenstein; A S Kaplan
Journal:  Virology       Date:  1975-08       Impact factor: 3.616

3.  Conversion of circular DNA to linear strands for mapping.

Authors:  R C Parker
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

4.  Role of glycoprotein gIII of pseudorabies virus in virulence.

Authors:  T C Mettenleiter; C Schreurs; F Zuckermann; T Ben-Porat; A S Kaplan
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

5.  Genome differences among field isolates and vaccine strains of pseudorabies virus.

Authors:  A L Gielkens; J T Van Oirschot; A J Berns
Journal:  J Gen Virol       Date:  1985-01       Impact factor: 3.891

6.  Mapping and sequence of the gene for the pseudorabies virus glycoprotein which accumulates in the medium of infected cells.

Authors:  T J Rea; J G Timmins; G W Long; L E Post
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

7.  Identification of functional regions in the transforming protein of Fujinami sarcoma virus by in-phase insertion mutagenesis.

Authors:  J C Stone; T Atkinson; M Smith; T Pawson
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

8.  Vaccination of swine with thymidine kinase-deficient mutants of pseudorabies virus.

Authors:  S McGregor; B C Easterday; A S Kaplan; T Ben-Porat
Journal:  Am J Vet Res       Date:  1985-07       Impact factor: 1.156

9.  Method for introducing site-specific mutations into adenovirus 2 genome: construction of a small deletion mutant in VA-RNAI gene.

Authors:  Q S Kapoor; G Chinnadurai
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

10.  Isolation, characterization, and physical mapping of a pseudorabies virus mutant containing antigenically altered gp50.

Authors:  M W Wathen; L M Wathen
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

View more
  19 in total

1.  Herpesviruses encode an unusual protein-serine/threonine kinase which is nonessential for growth in cultured cells.

Authors:  N de Wind; J Domen; A Berns
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

2.  Glycoprotein H of pseudorabies virus is essential for entry and cell-to-cell spread of the virus.

Authors:  B Peeters; N de Wind; R Broer; A Gielkens; R Moormann
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

3.  Role of pseudorabies virus Us3 protein kinase during neuronal infection.

Authors:  L M Olsen; T H Ch'ng; J P Card; L W Enquist
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Envelope glycoprotein gp50 of pseudorabies virus is essential for virus entry but is not required for viral spread in mice.

Authors:  B Peeters; J Pol; A Gielkens; R Moormann
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

5.  Characterization of Marek's disease virus insertion and deletion mutants that lack US1 (ICP22 homolog), US10, and/or US2 and neighboring short-component open reading frames.

Authors:  M S Parcells; A S Anderson; J L Cantello; R W Morgan
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  The pseudorabies virus homology of the herpes simplex virus UL21 gene product is a capsid protein which is involved in capsid maturation.

Authors:  N de Wind; F Wagenaar; J Pol; T Kimman; A Berns
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

7.  Equine herpesvirus 1 glycoprotein D: mapping of the transcript and a neutralization epitope.

Authors:  C C Flowers; D J O'Callaghan
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

8.  Deleting valine-125 and cysteine-126 in glycoprotein gI of pseudorabies virus strain NIA-3 decreases plaque size and reduces virulence in mice.

Authors:  L Jacobs; H J Rziha; T G Kimman; A L Gielkens; J T Van Oirschot
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

9.  Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro.

Authors:  J I Cohen; K E Seidel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

10.  Pseudorabies virus US3 protein kinase mediates actin stress fiber breakdown.

Authors:  Geert Van Minnebruggen; Herman W Favoreel; Liesbeth Jacobs; Hans J Nauwynck
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.